![Frontiers | Lung Cancer Stem Cell Markers as Therapeutic Targets: An Update on Signaling Pathways and Therapies Frontiers | Lung Cancer Stem Cell Markers as Therapeutic Targets: An Update on Signaling Pathways and Therapies](https://www.frontiersin.org/files/Articles/873994/fonc-12-873994-HTML/image_m/fonc-12-873994-g001.jpg)
Frontiers | Lung Cancer Stem Cell Markers as Therapeutic Targets: An Update on Signaling Pathways and Therapies
![Glowing tumor marker may interfere with cancer studies in mice, creating reproducibility problems | Science | AAAS Glowing tumor marker may interfere with cancer studies in mice, creating reproducibility problems | Science | AAAS](https://www.science.org/do/10.1126/science.ada1404/abs/_20220217_on_gfp.jpg)
Glowing tumor marker may interfere with cancer studies in mice, creating reproducibility problems | Science | AAAS
![Life | Free Full-Text | An Immunological Perspective of Circulating Tumor Cells as Diagnostic Biomarkers and Therapeutic Targets | HTML Life | Free Full-Text | An Immunological Perspective of Circulating Tumor Cells as Diagnostic Biomarkers and Therapeutic Targets | HTML](https://www.mdpi.com/life/life-12-00323/article_deploy/html/images/life-12-00323-ag.png)
Life | Free Full-Text | An Immunological Perspective of Circulating Tumor Cells as Diagnostic Biomarkers and Therapeutic Targets | HTML
![SETD3 acts as a prognostic marker in breast cancer patients and modulates the viability and invasion of breast cancer cells | Scientific Reports SETD3 acts as a prognostic marker in breast cancer patients and modulates the viability and invasion of breast cancer cells | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-59057-5/MediaObjects/41598_2020_59057_Fig1_HTML.png)
SETD3 acts as a prognostic marker in breast cancer patients and modulates the viability and invasion of breast cancer cells | Scientific Reports
![Organ-specific markers in circulating tumor cell screening: an early indicator of metastasis-capable malignancy | Future Oncology Organ-specific markers in circulating tumor cell screening: an early indicator of metastasis-capable malignancy | Future Oncology](https://www.futuremedicine.com/cms/10.2217/fon.11.32/asset/images/medium/figure1.gif)